Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC4497957/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC4497957/. The analysis below is for the second page.

Title[redir]:
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma - PMC
Description:
Blocking the interaction between the programmed cell death (PD)-1 protein and one of its ligands, PD-L1, has been reported to have impressive antitumor responses. Therapeutics targeting this pathway are currently in clinical trials. Pembrolizumab ...

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We find it hard to spot revenue streams.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Ncbi.nlm.nih.gov has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

pdl, doi, patients, response, melanoma, google, scholar, nivolumab, pubmed, tumor, blockade, cell, expression, clinical, cells, ipilimumab, pmc, cancer, article, tumors, immune, phase, free, nct, treatment, trials, igg, combination, rates, antipd, antibody, benefit, pembrolizumab, death, mpdla, reported, therapy, survival, events, clin, ctla, adverse, trial, responses, study, programmed, activity, inhibitors, pathway, checkpoint,

Topics {✒️}

line-melanoma-study-nivolumab-investigational-pd-1-checkpoint-inhibitor- 89 anti-pd-l1 antibody mpdl-3280a single-agent anti-programmed death-1 single-agent immune-checkpoint inhibition anti-pd-l1 monoclonal antibody pd-l2-fc fusion protein human anti-pd-l1 antibody itim motif-carrying immunoreceptor tumor-specific t-lymphocyte activity infected wild-type mice pd-l1– anti-pd-1 antibody‡ cytotoxic t-lymphocyte antigen murine anti-human b7-h1 t-lymphocyte activation lies anti-pd-l1 antibody mpdl3280a immune-mediated events occurred anti-pd-1 monoclonal antibody immune-related adverse events pd-1/pd-l1–targeted therapies mouse strain 129s4/svjae pd-1/pd-l1 checkpoint inhibitors anti-pd-l1 clone 5h1 lupus-prone lpr mutation engineered pd-l1 antibody �exhausted” t-cell phenotype rabbit anti-human mab intratumoral t-regulatory cells early t-lymphocyte tolerance anti-pd-l1 antibody 11 anti-pd-l1 antibody anti-pd-l1 blockades treatment-related adverse events pmc beta search graft-versus-leukemia effect anti-pd-1 therapeutic agent induce pd-l1 expression experienced dose-limiting toxicity graft-versus-host disease single immune-checkpoint inhibitor anti-pd-1 pathway family details unpublished pd-l1 anti-pd-l1 blockade anti-pd-1 antibody nivolumab immune-checkpoint inhibitors benefits antibody/tumor type/treatment immune-related response criteria b7-deficient mice reveal pd-l1 knockout mouse complement-dependent cytotoxicity anti-pd-l1 agents

Questions {❓}

  • Is PD-L1 Expression in Tumors a Predictive Biomarker?
  • The evolution of checkpoint blockade as a cancer therapy: what’s here, what’s next?

Social Networks {👍}(6)

External Links {🔗}(204)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

4.28s.